XSHG
600624
Market cap475mUSD
Oct 09, Last price
4.63CNY
1D
-1.28%
1Q
24.80%
Jan 2017
-46.16%
Name
SHANGHAI FUDAN FORWARD S&T CO LTD
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shanghai Fudan Forward S&T Co., Ltd maintains a diverse business portfolio encompassing software development, biopharmaceuticals, and property ventures. Its software division specializes in creating and exporting programs, notably to the Japanese market. Within its biopharmaceutical operations, the firm conducts comprehensive research, development, manufacturing, and distribution of a range of products, including chemical drugs, traditional Chinese medicines, freeze-dried powder injections, and various solid dosage forms. The company's real estate arm focuses on the conceptualization and establishment of high-tech industrial parks. Beyond these, the enterprise is involved in the design, production, and sale of uninterruptible power supplies (UPS) and VRLA batteries, and also serves as an official agent for an automotive audio brand. Complementing these activities, it provides investment and advisory services, alongside venture capital funding. Founded in 1984, Shanghai Fudan Forward S&T Co., Ltd is headquartered in Shanghai, China.
Key people
Wenbin Zhao
Chairman of the Board · since 2017
Weida Ye
Finance Director · since 2005
Hanwei Chen
Deputy General Manager · since 2008
Fangfang Ma
Deputy General Manager · since 2008
Linfang Ren
Secretary of the Board, Deputy General Manager, Director
Wansu Ye
Deputy General Manager · since 2003
Independent Director · since 2008
Zhiyuan Liu
Independent Director · since 2009
Bojun Wu
Independent Director · since 2008
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||